Jayson Rieger
CEO and President at Verrica Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Verrica Pharmaceuticals Inc., 1 year.
Verrica Pharmaceuticals Inc.
Director · CEO and President
Chief executive roles
Verrica Pharmaceuticals Inc.
· CEO and President
Since November 2024
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 2026 | Verrica Pharmaceuticals Inc. | Open-market purchase | +5,000 | $4.91 | $24,550 |
| Aug 14, 2026 | Verrica Pharmaceuticals Inc. | Open-market purchase | +20,000 | $5.06 | $101,200 |
| Nov 25, 2025 | Verrica Pharmaceuticals Inc. | Open-market purchase | +94,311 | $4.24 | $399,879 |
| Nov 26, 2024 | Verrica Pharmaceuticals Inc. | Gift | +50,000 | — | — |
| Nov 22, 2024 | Verrica Pharmaceuticals Inc. | Open-market purchase | +280,898 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.